Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920009'
s FCF Margin % Range Over the Past 10 Years
Min: 14.76 Med: 31.65 Max: 41.59
Current: 32.96
During the past 9 years, the highest FCF Margin % of Dynamiker Biotechnology (Tianjin) Co was 41.59%. The lowest was 14.76%. And the median was 31.65%.
BJSE:920009's FCF Margin % is ranked better than 96.98% of 959
companies
in the Drug Manufacturers industry
Industry Median: 2.4
vs BJSE:920009: 32.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co FCF Margin % Chart
BJSE:920009 vs LLY, JNJ, ABBV: FCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamiker Biotechnology (Tianjin) Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a FCF Margin % of -3.65% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. Over the past decade, Dynamiker Biotechnology (Tianjin) Co's FCF Margin % has ranged from 14.76 to 41.59. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #29 out of 959 companies in the Drug Manufacturers industry, placing it in the top 3%.
Is Dynamiker Biotechnology (Tianjin) Co's FCF Margin % too high?
Dynamiker Biotechnology (Tianjin) Co's current FCF Margin % is -3.65%. Over the past 10 years, this metric has ranged from a low of 14.76 to a high of 41.59. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #29 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #29 out of 959 companies for FCF Margin %. This places Dynamiker Biotechnology (Tianjin) Co in the top 3% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.40. Historically, Dynamiker Biotechnology (Tianjin) Co's own FCF Margin % has ranged from 14.76 to 41.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.40, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current FCF Margin % is -3.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current FCF Margin % of -3.65%. The current FCF Margin % is -3.65%. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current FCF Margin % is -3.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score
Get the complete analysis for BJSE:920009
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920009 has been successfully added to your 
